Insulin Receptor Substrate 2 and Neuronal Insulin Resistance in Diabetic Neuropathy
Author Information
Author(s): C. W. Grote, Morris J. K., Ryals J. M., Geiger P. C., Wright D. E.
Primary Institution: The University of Kansas Medical Center
Hypothesis
Elevated serine phosphorylation of IRS2 impairs insulin signaling in sensory neurons and contributes to diabetic neuropathy.
Conclusion
The study found that IRS2 expression is altered in diabetic mice, leading to impaired insulin signaling in sensory neurons.
Supporting Evidence
- IRS2 is the predominant isoform expressed in dorsal root ganglia.
- Serine phosphorylation of IRS2 was significantly elevated in diabetic mice.
- Akt activation and neurite outgrowth in response to insulin were significantly decreased in diabetic mice.
- Insulin signaling in DRG neurons is impaired in diabetic conditions.
Takeaway
Diabetes can make it harder for nerves to respond to insulin, which is important for their health. This study looked at how a protein called IRS2 is affected by diabetes in nerve cells.
Methodology
The study used mouse models of type 1 and type 2 diabetes to analyze IRS expression and insulin signaling in dorsal root ganglia neurons through various biochemical assays.
Limitations
The study primarily focused on mouse models, which may not fully replicate human diabetic neuropathy.
Participant Demographics
The study involved male C57Bl/6 mice and ob/ob mice, aged 8 weeks.
Statistical Information
P-Value
p<0.05
Statistical Significance
p<0.05
Digital Object Identifier (DOI)
Want to read the original?
Access the complete publication on the publisher's website